Piotr Wajda
Papers
1
Total Citations
3
H-Index
1
About
Dr. Piotr Wajda is a pioneering figure in cell-based assay technology, whose work is reshaping preclinical drug development. His primary research focus lies in the engineering of high-throughput, cost-efficient platforms for phenotypic screening, with a particular emphasis on miniaturized cell arrays. Dr. Wajda’s most significant contribution is the development of high-density cell arrays, a breakthrough technology that dramatically reduces the time and cost associated with genome-scale screening. His landmark 2019 paper on this subject, which has garnered 3 citations, introduces a novel method that enables researchers to test diverse biologicals and conduct preclinical development with unprecedented efficiency. By addressing the long-standing barriers of high costs and considerable time investments in cell-based assays, Dr. Wajda’s work has opened new avenues for large-scale functional genomics and drug discovery. His innovative approach not only accelerates the pace of research but also democratizes access to advanced screening technologies, making them more feasible for a wider range of laboratories. Dr. Wajda’s contributions are particularly valuable for students and researchers seeking to navigate the complexities of modern cell biology and translational medicine.
Research Focus
Key Achievements
Top Papers
- 1High-Density Cell Arrays for Genome-Scale Phenotypic Screening3 citations · 2019